PCSA

Processa Pharmaceuticals Inc

• PUBT·05/19 22:06

  Processa CEO George Ng buys 1,843 shares for $5,472.71

• PUBT·05/19 22:05

  Processa R&D President David Young acquires 1,545 shares worth $4,588.65

• PUBT·05/19 22:02

  Processa Chief Business-Strategy Officer Patrick Lin acquires 1,369 shares for $4,065.93

• PUBT·05/19 21:38

  Processa Pharma CAO Wendy Guy acquires 1,583 common shares worth $4,702.51

• PUBT·05/19 21:36

  Processa CFO Russell Skibsted acquires 1,984 shares for $5,892.48

• PUBT·05/07 21:25

  Processa Pharmaceuticals Q1 net loss widens to $3.38 million

• PUBT·05/01 20:40

  Processa R&D President David Young acquires 1,706 shares for $4,589.14

• PUBT·05/01 20:39

  Processa CFO Russell Skibsted buys 2,190 shares worth $5,891.1

• PUBT·05/01 20:38

  Processa CEO George Ng acquires $5,472.46 of common shares

• PUBT·05/01 20:37

  Processa Chief Business-Strategy Officer Patrick Lin buys 1,511 shares for $4,065.59

• PUBT·05/01 20:36

  Processa CAO Wendy Guy buys 1,748 shares for $4,704.12

• PUBT·05/01 20:35

  Processa Chief Development Officer Sian Bigora buys 1,986 shares for $5,342.34

• TipRanks·04/30 22:46

  Processa Pharmaceuticals Announces Transition of Chief Development Officer

• PUBT·04/30 21:58

  Processa’s Bigora shifts to part-time role in retirement transition

• PUBT·04/17 20:55

  Processa Pharmaceuticals Pres. R&D David Young acquires 1,545 shares for $4,586.65